The panograph in cancer patients receiving myelosuppressive chemotherapy.

被引：0
|
作者：
Catanzano, J [1 ]
Weikel, D [1 ]
Favilla, E [1 ]
Elsabagh, A [1 ]
Overholser, C [1 ]
Meiller, T [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
JOURNAL OF DENTAL RESEARCH | 1998年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
11
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] A phase I trial of PT-100 in patients receiving myelosuppressive chemotherapy.
    Nemunaitis, JJ
    Cunningham, CC
    Senzer, NN
    Haltom, E
    Jones, B
    Vukelja, SJ
    Richards, DA
    Uprichard, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 181S - 181S
  • [2] Udenyca has equivalent efficacy to the pegfilgrastim originator in breast cancer patients receiving highly myelosuppressive chemotherapy.
    Webster, Jennifer
    Scott, Jeffrey A.
    Smith, Helen
    Wieland, Danielle
    Donaldson, Joseph
    Catasus, Casey
    Smith, Robert E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Determinants of anemia in cancer patients receiving chemotherapy.
    Robertson, C
    Boyle, P
    Kerr, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 889S - 889S
  • [4] Anemia and neutropenia in cancer patients receiving chemotherapy.
    Boyle, P
    Robertson, C
    Kerr, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 886S - 886S
  • [5] Pharmacokinetics (PK) of intravenously (IV) administered epoetin alfa in pediatric patients receiving myelosuppressive chemotherapy.
    Freeman, BB
    Iacono, LC
    Hinds, PS
    Razzouk, BI
    Stewart, CF
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 812S - 812S
  • [6] Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy.
    Cosler, LE
    Eldar-Lissai, A
    Dale, DC
    Crawford, J
    Lyman, GH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 538S - 538S
  • [7] First and subsequent cycle pegfilgrastim results in low rates of neutropenic events in patients receiving myelosuppressive chemotherapy.
    Rader, ME
    Breyer, W
    Luedke, S
    Truscinski, D
    Ding, B
    Dansey, R
    Ozer, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S215 - S216
  • [8] Dietary intake in patients with advanced cancer patients receiving chemotherapy.
    Harvie, MN
    Campbell, IT
    Thatcher, N
    Howell, A
    Baildam, A
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2000, 59 : 167A - 167A
  • [9] Influence of hemoglobin response to epoetin alfa on quality-of-life in anemic children with cancer receiving myelosuppressive chemotherapy.
    Razzouk, BI
    Hockenberry, M
    Hinds, PS
    Feusner, J
    Rackoff, W
    Hord, JD
    BLOOD, 2004, 104 (11) : 609A - 610A
  • [10] The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy
    Lyman, G. H.
    Reiner, M.
    Morrow, P. K.
    Crawford, J.
    ANNALS OF ONCOLOGY, 2015, 26 (07) : 1452 - 1458
12345